Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bimal Bhindi

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Urologic Oncology|September 24, 2021
Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborativeBenjamin Shiff, Rodney H Breau, Ranjeeta Mallick, et al.
The Journal of Urology|June 10, 2022
A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results from the Canadian Kidney Cancer Information SystemBraden Millan, Rodney H Breau, Bimal Bhindi, et al.
Urologic Oncology|August 8, 2017
Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicionBimal Bhindi, Haiyan Jiang, Cedric Poyet, et al.
European Urology|May 27, 2017
Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched AnalysisBimal Bhindi, Igor Frank, Ross J Mason, et al.
Urology|March 27, 2016
Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade, and Overall Recurrence Risk in Men Undergoing Radical ProstatectomyBimal Bhindi, Wen Y Xie, Girish S Kulkarni, et al.
British Journal of Cancer|December 15, 2015
Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomyBimal Bhindi, Thomas Hermanns, Yanliang Wei, et al.
Urologic Oncology|December 14, 2020
Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinomaElizabeth N Bearrick, Vignesh Packiam, Bimal Bhindi, et al.
European Urology|July 19, 2018
The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and TreatmentBimal Bhindi, R Houston Thompson, Christine M Lohse, et al.
Urology|December 3, 2014
The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsyBimal Bhindi, David Margel, Robert J Hamilton, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 13, 2023
2023 UPDATE - Canadian Urological Association guideline: Management of cystic renal lesions Prior to original publication (March 2017), this guideline underwent review by the CUA Guidelines Committee, CUA members at large, and the CUA Executive Board. The 2023 updates were app roved by the CUA Guidelines Committee and CUA Executive BoardPatrick O Richard, Philippe D Violette, Bimal Bhindi, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Urologic Oncology|September 24, 2021
Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborativeBenjamin Shiff, Rodney H Breau, Ranjeeta Mallick, et al.
The Journal of Urology|June 10, 2022
A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results from the Canadian Kidney Cancer Information SystemBraden Millan, Rodney H Breau, Bimal Bhindi, et al.
Urologic Oncology|August 8, 2017
Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicionBimal Bhindi, Haiyan Jiang, Cedric Poyet, et al.
European Urology|May 27, 2017
Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched AnalysisBimal Bhindi, Igor Frank, Ross J Mason, et al.
Urology|March 27, 2016
Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade, and Overall Recurrence Risk in Men Undergoing Radical ProstatectomyBimal Bhindi, Wen Y Xie, Girish S Kulkarni, et al.
British Journal of Cancer|December 15, 2015
Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomyBimal Bhindi, Thomas Hermanns, Yanliang Wei, et al.
Urologic Oncology|December 14, 2020
Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinomaElizabeth N Bearrick, Vignesh Packiam, Bimal Bhindi, et al.
European Urology|July 19, 2018
The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and TreatmentBimal Bhindi, R Houston Thompson, Christine M Lohse, et al.
Urology|December 3, 2014
The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsyBimal Bhindi, David Margel, Robert J Hamilton, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 13, 2023
2023 UPDATE - Canadian Urological Association guideline: Management of cystic renal lesions Prior to original publication (March 2017), this guideline underwent review by the CUA Guidelines Committee, CUA members at large, and the CUA Executive Board. The 2023 updates were app roved by the CUA Guidelines Committee and CUA Executive BoardPatrick O Richard, Philippe D Violette, Bimal Bhindi, et al.
Pageof 12